Dennis Mulroy, CHIEF FINANCIAL OFFICER at ANAPTYSBIO, INC (ANAB), sold 31,450 shares at $44.62 ($1.4M) on 2025-12-16, disclosed to the SEC on 2025-12-18.
Scheduled sale ($1.4M) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.62 | 9,365 | $418K | 29.6% |
| 2 | $44.62 | 9,365 | $418K | 29.6% |
| 3 | $45.21 | 6,360 | $288K | 20.4% |
| 4 | $45.21 | 6,360 | $288K | 20.4% |
| Total | $44.86 avg | 31,450 | $1.4M | 100% |
| Filing → |
| ANAB | SELL | 2026-01-06 | $145K | — | Filing → |
| ANAB | SELL | 2025-12-23 | $500K | — | Filing → |
| ANAB | SELL | 2024-09-17 | $574K | — | Filing → |